Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection.

Cohen C, Elion R, Ruane P, Shamblaw D, DeJesus E, Rashbaum B, Chuck SL, Yale K, Liu HC, Warren DR, Ramanathan S, Kearney BP.

AIDS. 2011 Mar 27;25(6):F7-12. doi: 10.1097/QAD.0b013e328345766f.

PMID:
21412057
[PubMed - indexed for MEDLINE]
2.

Combinational therapies for HIV: a focus on EVG/COBI/FTC/TDF.

Schrijvers R, Debyser Z.

Expert Opin Pharmacother. 2012 Sep;13(13):1969-83. doi: 10.1517/14656566.2012.712514. Epub 2012 Jul 31. Review.

PMID:
22849516
[PubMed - indexed for MEDLINE]
3.

WITHDRAWN: Effectiveness and safety of first-line tenofovir + emtricitabine + efavirenz for patients with HIV.

Omeje I, Okwundu CI.

Cochrane Database Syst Rev. 2012 May 16;5:CD007276. doi: 10.1002/14651858.CD007276.pub3. Review.

PMID:
22592718
[PubMed - indexed for MEDLINE]
4.

WITHDRAWN. Effectiveness and safety of first-line tenofovir + emtricitabine + efavirenz for patients with HIV.

Omeje I, Okwundu CI.

Cochrane Database Syst Rev. 2012 Feb 15;2:CD007276. doi: 10.1002/14651858.CD007276.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;5:CD007276.

PMID:
22336829
[PubMed - indexed for MEDLINE]
5.

Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single tablet for HIV-1 infection treatment.

Olin JL, Spooner LM, Klibanov OM.

Ann Pharmacother. 2012 Dec;46(12):1671-7. doi: 10.1345/aph.1R468. Epub 2012 Nov 7. Review.

PMID:
23136357
[PubMed - indexed for MEDLINE]
6.

Emtricitabine/tenofovir disoproxil fumarate: a review of its use in HIV-1 pre-exposure prophylaxis.

Plosker GL.

Drugs. 2013 Mar;73(3):279-91. doi: 10.1007/s40265-013-0024-4. Review.

PMID:
23444256
[PubMed - indexed for MEDLINE]
7.

Tenofovir disoproxil fumarate-emtricitabine coformulation for once-daily dual NRTI backbone.

Muñoz de Benito RM, Arribas López JR.

Expert Rev Anti Infect Ther. 2006 Aug;4(4):523-35. Review.

PMID:
17009933
[PubMed - indexed for MEDLINE]
8.

Efavirenz/emtricitabine/tenofovir disoproxil fumarate fixed-dose combination: first-line therapy for all?

Goicoechea M, Best B.

Expert Opin Pharmacother. 2007 Feb;8(3):371-82. Review.

PMID:
17266471
[PubMed - indexed for MEDLINE]
9.

A review of the virological efficacy of the 4 World Health Organization-recommended tenofovir-containing regimens for initial HIV therapy.

Tang MW, Kanki PJ, Shafer RW.

Clin Infect Dis. 2012 Mar;54(6):862-75. doi: 10.1093/cid/cir1034. Review.

PMID:
22357809
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Elvitegravir: a once-daily inhibitor of HIV-1 integrase.

Wills T, Vega V.

Expert Opin Investig Drugs. 2012 Mar;21(3):395-401. doi: 10.1517/13543784.2012.658914. Epub 2012 Feb 10. Review.

PMID:
22321026
[PubMed - indexed for MEDLINE]
11.

Emtricitabine/tenofovir disoproxil fumarate.

[No authors listed]

Drugs R D. 2004;5(3):160-1. Review.

PMID:
15139777
[PubMed - indexed for MEDLINE]
12.

EFV/FTC/TDF-associated hepatotoxicity: a case report and review.

Echenique IA, Rich JD.

AIDS Patient Care STDS. 2013 Sep;27(9):493-7. doi: 10.1089/apc.2013.0008. Epub 2013 Aug 12. Review.

PMID:
23937548
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Emtricitabine/tenofovir in the treatment of HIV infection: current PK/PD evaluation.

Uglietti A, Zanaboni D, Gnarini M, Maserati R.

Expert Opin Drug Metab Toxicol. 2012 Oct;8(10):1305-14. doi: 10.1517/17425255.2012.714367. Epub 2012 Sep 4. Review.

PMID:
22943210
[PubMed - indexed for MEDLINE]
14.

Efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Atripla®): a review of its use in the management of HIV infection.

Deeks ED, Perry CM.

Drugs. 2010 Dec 3;70(17):2315-38. doi: 10.2165/11203800-000000000-00000. Review.

PMID:
21080746
[PubMed - indexed for MEDLINE]
15.

Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals.

Okwundu CI, Uthman OA, Okoromah CA.

Cochrane Database Syst Rev. 2012 Jul 11;7:CD007189. doi: 10.1002/14651858.CD007189.pub3. Review.

PMID:
22786505
[PubMed - indexed for MEDLINE]
16.

Elvitegravir: a once-daily, boosted, HIV-1 integrase inhibitor.

Lampiris HW.

Expert Rev Anti Infect Ther. 2012 Jan;10(1):13-20. doi: 10.1586/eri.11.157. Review.

PMID:
22149610
[PubMed - indexed for MEDLINE]
17.

Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals.

Spaulding A, Rutherford GW, Siegfried N.

Cochrane Database Syst Rev. 2010 Oct 6;(10):CD008740. doi: 10.1002/14651858.CD008740. Review.

PMID:
20927777
[PubMed - indexed for MEDLINE]
18.

Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines.

Colombo GL, Di Matteo S, Antinori A, Medaglia M, Murachelli S, Rizzardini G.

Clinicoecon Outcomes Res. 2013 Oct 3;5:489-96. doi: 10.2147/CEOR.S48246. Review.

PMID:
24124383
[PubMed]
Free PMC Article
19.

The first once-daily single-tablet regimen for the treatment of HIV-infected patients.

Killingley B, Pozniak A.

Drugs Today (Barc). 2007 Jul;43(7):427-42. Review.

PMID:
17728844
[PubMed - indexed for MEDLINE]
20.

Preexposure prophylaxis for HIV prevention: where have we been and where are we going?

Baeten JM, Haberer JE, Liu AY, Sista N.

J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2:S122-9. doi: 10.1097/QAI.0b013e3182986f69. Review.

PMID:
23764623
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk